Saturday, 25 May 2013

• Final Glance: Pharmaceuticals companiesAP (Sat 08:03)
• Promising Data on ONCY's ReolysinZacks (Sat 06:10)

Tuesday, 23 April 2013

• Former Pro Football Coach Bill Cowher Tells Men “No Excuses” When It Comes to Getting Screened for Melanomaat noodls (Tue 23 Apr)

Monday, 8 April 2013

• Bristol-Myers Squibb to Present New Data on Hepatitis C and Hepatitis B Compounds at The International Liver CongressTM (ILC) 2013at noodls (Mon 8 Apr)

Wednesday, 26 December 2012

• ELIQUIS® (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial FibrillationBusiness Wire (Wed 26 Dec)

Thursday, 15 November 2012

• PropThink: Does Achillion Have a Place in the HCV Market of the Future?ACN Newswire (Thu 15 Nov)
• Bristol-Myers Squibb Foundation’s Together on Diabetes™ Marks World Diabetes Day with Second Annual Report and Two New Grants in IndiaBusiness Wire (Thu 15 Nov)

Tuesday, 13 November 2012

• PropThink: Lightweight Contender ACHN Declines on Gilead's Latest Hepatitis DataACN Newswire (Tue 13 Nov)

Thursday, 8 November 2012

• Bristol-Myers Squibb Foundation Announces Centers of Excellence Conference to Share Insights from Asian-Pacific Community Groups on Viral Hepatitis Management in Honor of the 10-Year Anniversary of Delivering Hope™Business Wire (Thu 8 Nov)

Saturday, 3 November 2012

• PropThink: Gilead and the Pharmasset Deal: Do the Ends Justify the Means?ACN Newswire (Sat 3 Nov)

Thursday, 1 November 2012

• PropThink: BioCryst and Presidio's Priorities May Shift with FDA ConcernsACN Newswire (Thu 1 Nov)

Tuesday, 16 October 2012

• PropThink: Abbot's Impressive HCV Data Continues the Trend; Everyone's Got a CandidateACN Newswire (Tue 16 Oct)

Saturday, 13 October 2012

• PropThink: Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage PipelineACN Newswire (Sat 13 Oct)

Thursday, 4 October 2012

• PropThink: ARIAD Building an Oncology Business Around Discovery, Development, and CommercializationACN Newswire (Thu 4 Oct)

Monday, 1 October 2012

• PropThink: Sickle Cell Drug Finding New Opportunity at ADVENTRX PharmaceuticalsACN Newswire (Mon 1 Oct)

Friday, 28 September 2012

• PropThink: ACHN Keeps Advancing, Visibility As Leader In Next-Gen HCV Drugs IncreasesACN Newswire (Fri 28 Sep)

Thursday, 27 September 2012

• PropThink: Vertex Drops One Drug, Advances Another as HCV Segment Heats UpACN Newswire (Thu 27 Sep)

Saturday, 22 September 2012

• PropThink: SciClone Reportedly Exploring Strategic OptionsACN Newswire (Sat 22 Sep)

Wednesday, 19 September 2012

• PropThink: ACHN, IDIX Pair Trade Continues To Gain TractionACN Newswire (Wed 19 Sep)

Friday, 31 August 2012

• PropThink: Achillion Raises Cash but Market Reacts PositivelyACN Newswire (Fri 31 Aug)